Sign in

NCT04568967Completed

TB-CAPT EXULTANT - HIV

Expanding Xpert Ultra Testing for TB Diagnosis Among HIV-positive Patients Admitted to Hospital in Africa

Source: ClinicalTrials.gov · Last updated 4 Apr 2025

Brief summary (registry, in English)

The overall aim of this study is to assess the potential of an expanded TB testing strategy to increase the number of HIV-positive patients with microbiologically diagnosed TB who are started on treatment in adult wards of sub-Saharan Africa.

Status (registry)
Completed
Study type
Interventional
Enrollment
1172 (actual)
First submitted
23 Sept 2020
Start date
5 Sept 2022
Primary completion date
31 Dec 2024
Lead sponsor
Foundation for Innovative New Diagnostics, Switzerland
Diseases
Tuberculosis, HIV
NCT number
NCT04568967

What you commit to

  • Study type: Interventional
  • Participants enrolled: 1172
  • From 5 Sept 2022 to the primary completion date, 31 Dec 2024
  • 4 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently receiving anti-TB therapy or having received anti TB therapy in the last 6 months prior to enrolment
  • Receiving preventive TB treatment in the preceding 6 months

Other illness

  • Patients admitted for traumatic reasons, acute abdomen, delivery (maternal conditions), or for planned/scheduled surgery.

Other

  • Unable to provide informed consent (if no authorized relatives are in the position to provide the consent)
  • Living outside the catchment area of the participating hospital(s)
  • with plans to migrate outside the catchment area within 2 months after recruitment.
  • Referred from other hospital.

Who the study is looking for

  • Adults (18 years old and above)
  • Confirmed HIV infection by serology (including both antiretroviral (ART)- naïve and experienced)
  • Admitted to the hospital (adult medical wards) at the time of enrolment.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centro de Investigação em Saúde de Manhiça-Fundação
Coordinator of this site? Confirm its status
ManhiçaMozambiqueUnknown status
Instituto Nacional de Saúde (INS)
Coordinator of this site? Confirm its status
MaputoMozambiqueUnknown status
Ifakara Health Institute (IHI)
Coordinator of this site? Confirm its status
BagamoyoTanzaniaUnknown status
National Institute of Medical Research (NIMR)
Coordinator of this site? Confirm its status
MbeyaTanzaniaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.